<DOC>
	<DOC>NCT01625403</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of recombinant human B-type natriuretic peptide (rhBNP) on heart and renal function in patients with acute decompensated heart failure (ADHF) and acute renal injury (AKI).</brief_summary>
	<brief_title>Recombinant BNP on Heart and Renal Function in Acute Heart Failure</brief_title>
	<detailed_description>Patients with acute decompensated heart failure (ADHF) and acute renal injury (AKI) will be randomized to receive standard of care with or without additional rhBNP. Clinical heart function, LVEF, SCr, GFR and other laboratory parameters will be evaluated.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>acute heart failure with acute renal injury not tolerate to rhBNP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Recombinant BNP</keyword>
	<keyword>Diuretics</keyword>
	<keyword>Acute decompensated heart failure</keyword>
	<keyword>Acute renal injury</keyword>
	<keyword>Heart function</keyword>
	<keyword>Renal function</keyword>
</DOC>